28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

NCT00398580 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism
Hypogonadism, Male

Interventions

DRUG: Nanomilled testosterone
DRUG: Nanomilled dutasteride
DRUG: commercially available dutasteride

Sponsor

GlaxoSmithKline